{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T02:48:44Z","timestamp":1771469324225,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.clinthera.2009.05.022","type":"journal-article","created":{"date-parts":[[2009,8,19]],"date-time":"2009-08-19T08:25:15Z","timestamp":1250670315000},"page":"1177-1191","source":"Crossref","is-referenced-by-count":114,"title":["Efficacy and tolerability of intranasal fentanyl spray 50 to 200 \u03bcg for breakthrough pain in patients with cancer: A phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period"],"prefix":"10.1016","volume":"31","author":[{"given":"Hans Georg","family":"Kress","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Oro\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zbigniew","family":"Kaczmarek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stein","family":"Kaasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torben","family":"Colberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Nolte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2009.05.022_bib1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0304-3959(90)90004-W","article-title":"Breakthrough pain: Definition, prevalence and characteristics","volume":"41","author":"Portenoy","year":"1990","journal-title":"Pain"},{"key":"10.1016\/j.clinthera.2009.05.022_bib2_1","first-page":"1035","article-title":"Breakthrough pain in cancer patients: Characteristics, prevalence, and treatment","volume":"12","author":"Patt","year":"1998","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.clinthera.2009.05.022_bib2_2","first-page":"1049","article-title":"Breakthrough pain in cancer patients: Characteristics, prevalence, and treatment","volume":"12","author":"Patt","year":"1998","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.clinthera.2009.05.022_bib3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0885-3924(00)00161-5","article-title":"Prevalence and characteristics of breakthrough pain in cancer patients admitted to a hospice [published correction appears in J Pain Symptom Manage. 2001;21:265]","volume":"20","author":"Zeppetella","year":"2000","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.clinthera.2009.05.022_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0885-3924(02)00421-9","article-title":"Breakthrough cancer pain: Prevalence and characteristics in patients in Catalonia, Spain","volume":"24","author":"G\u00f3mez-Batiste","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.clinthera.2009.05.022_bib5","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/cncr.10249","article-title":"Episodic (breakthrough) pain: Consensus conference of an expert working group of the European Association for Palliative Care","volume":"94","author":"Mercadante","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.clinthera.2009.05.022_bib6","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1191\/0269216305pm1054oa","article-title":"Pain and pain treatments in European palliative care units. A cross sectional survey from the European Association for Palliative Care Research Network","volume":"19","author":"Klepstad","year":"2005","journal-title":"Palliat Med"},{"key":"10.1016\/j.clinthera.2009.05.022_bib7","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0885-3924(98)00094-3","article-title":"Peak plasma concentrations after oral morphine: A systematic review","volume":"16","author":"Collins","year":"1998","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.clinthera.2009.05.022_bib8","series-title":"Clinical pharmacology of opioid agonists and partial agonists","first-page":"17","author":"Thompson","year":"1990"},{"key":"10.1016\/j.clinthera.2009.05.022_bib9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0304-3959(00)00427-9","article-title":"Breakthrough cancer pain: A randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR)","volume":"91","author":"Coluzzi","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.clinthera.2009.05.022_bib10","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/01.ajp.0000210932.27945.4a","article-title":"A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer","volume":"22","author":"Portenoy","year":"2006","journal-title":"Clin J Pain"},{"key":"10.1016\/j.clinthera.2009.05.022_bib11","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1034\/j.1399-6576.2002.460702.x","article-title":"Nasal administration of opioids for pain management in adults","volume":"46","author":"Dale","year":"2002","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.clinthera.2009.05.022_bib12","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1097\/00000542-200012000-00006","article-title":"Use of intranasal fentanyl in children undergoing myringotomy and tube placement during halothane and sevoflurane anesthesia","volume":"93","author":"Galinkin","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1016\/j.clinthera.2009.05.022_bib13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00000542-199208000-00010","article-title":"Postoperative pain management by intranasal demand-adapted fentanyl titration","volume":"77","author":"Striebel","year":"1992","journal-title":"Anesthesiology"},{"key":"10.1016\/j.clinthera.2009.05.022_bib14","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1365-2044.1993.tb07583.x","article-title":"Intranasal fentanyl titration for postoperative pain management in an unselected population","volume":"48","author":"Striebel","year":"1993","journal-title":"Anaesthesia"},{"key":"10.1016\/j.clinthera.2009.05.022_bib15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0952-8180(95)00167-0","article-title":"Patient-controlled intranasal analgesia (PCINA) for the management of postoperative pain: A pilot study","volume":"8","author":"Striebel","year":"1996","journal-title":"J Clin Anesth."},{"key":"10.1016\/j.clinthera.2009.05.022_bib16","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1213\/00000539-199609000-00019","article-title":"Patient-controlled intranasal analgesia: A method for noninvasive postoperative pain management","volume":"83","author":"Striebel","year":"1996","journal-title":"Anesth Analg."},{"key":"10.1016\/j.clinthera.2009.05.022_bib17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF03020941","article-title":"Patient-controlled intranasal analgesia: Effective alternative to intravenous PCA for postoperative pain relief","volume":"47","author":"Toussaint","year":"2000","journal-title":"Can J Anaesth."},{"key":"10.1016\/j.clinthera.2009.05.022_bib18","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/BF03020494","article-title":"Intranasal fenta-nyl provides adequate postoperative analgesia in pediatric patients","volume":"49","author":"Manjushree","year":"2002","journal-title":"Can J Anaesth."},{"key":"10.1016\/j.clinthera.2009.05.022_bib19","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1046\/j.1365-2044.2003.03286.x","article-title":"A new formulation of nasal fentanyl spray for postoperative analgesia: A pilot study","volume":"58","author":"Paech","year":"2003","journal-title":"Anaesthesia"},{"key":"10.1016\/j.clinthera.2009.05.022_bib20","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1046\/j.1365-2044.2003.03295_24.x","article-title":"Intranasal fentanyl for postoperative analgesia after elective Caesarean section","volume":"58","author":"Wong","year":"2003","journal-title":"Anaesthesia"},{"key":"10.1016\/j.clinthera.2009.05.022_bib21","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1442-2026.2002.00344.x","article-title":"Intranasal fentanyl reduces acute pain in children in the emergency department: A safety and efficacy study","volume":"14","author":"Borland","year":"2002","journal-title":"Emerg Med (Fremantle)"},{"key":"10.1016\/j.clinthera.2009.05.022_bib22","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.burns.2003.10.017","article-title":"A randomised crossover trial of patient controlled intranasal fentanyl and oral morphine for procedural wound care in adult patients with burns","volume":"30","author":"Finn","year":"2004","journal-title":"Burns."},{"key":"10.1016\/j.clinthera.2009.05.022_bib23","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.burns.2005.05.001","article-title":"Intranasal fen-tanyl is an equivalent analgesic to oral morphine in paedi-atric burns patients for dressing changes: A randomised double blind crossover study","volume":"31","author":"Borland","year":"2005","journal-title":"Burns."},{"key":"10.1016\/j.clinthera.2009.05.022_bib24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0885-3924(00)00180-9","article-title":"An assessment of the safety, efficacy, and acceptability of intranasal fentanyl citrate in the management of cancer-related breakthrough pain: A pilot study","volume":"20","author":"Zeppetella","year":"2000","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.clinthera.2009.05.022_bib25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1191\/026921600668793500","article-title":"Nebulized and intranasal fentanyl in the management of cancer-related breakthrough pain","volume":"14","author":"Zeppetella","year":"2000","journal-title":"Palliat Med."},{"key":"10.1016\/j.clinthera.2009.05.022_bib26","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<984::AID-CNCR6>3.0.CO;2-0","article-title":"Salivary flow and its relation with oral symptoms in terminally ill patients","volume":"88","author":"Chaushu","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.clinthera.2009.05.022_bib27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1368-8375(97)00076-6","article-title":"Oral disease in terminally ill cancer patients with xerostomia","volume":"34","author":"Sweeney","year":"1998","journal-title":"Oral Oncol."},{"key":"10.1016\/j.clinthera.2009.05.022_bib28","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jpainsymman.2005.11.006","article-title":"Oral transmu-cosal fentanyl citrate and xerostomia","volume":"30","author":"Davies","year":"2005","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.clinthera.2009.05.022_bib29","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.clinthera.2008.03.001","article-title":"Pharmacokinetics, efficacy, and tolerability of fentanyl following intranasal versus intravenous administration in adults undergoing third-molar extraction: A randomized, double-blind, double-dummy, two-way, crossover study","volume":"30","author":"Christrup","year":"2008","journal-title":"Clin Ther."},{"key":"10.1016\/j.clinthera.2009.05.022_bib30","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00228-007-0444-8","article-title":"Early pharmacokinetics of nasal fentanyl: Is there a significant arterio-venous difference?","volume":"64","author":"Moksnes","year":"2008","journal-title":"Eur J Clin Pharmacol."},{"key":"10.1016\/j.clinthera.2009.05.022_bib31","unstructured":"World Medical Association Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects. Helsinki 1964, amended in Tokyo 1975, Venice 1983, Hong Kong 1989, South Africa 1996, and Edinburgh 2000."},{"key":"10.1016\/j.clinthera.2009.05.022_bib32_1","first-page":"695","article-title":"An alternative algorithm for dosing transdermal fentanyl for cancer-related pain","volume":"14","author":"Breitbart","year":"2000","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.clinthera.2009.05.022_bib32_2","first-page":"705","article-title":"An alternative algorithm for dosing transdermal fentanyl for cancer-related pain","volume":"14","author":"Breitbart","year":"2000","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.clinthera.2009.05.022_bib32_3","first-page":"709","article-title":"An alternative algorithm for dosing transdermal fentanyl for cancer-related pain","volume":"14","author":"Breitbart","year":"2000","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.clinthera.2009.05.022_bib33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0304-3959(00)00435-8","article-title":"Seeking a simple measure of analgesia for mega-trials: Is a single global assessment good enough?","volume":"91","author":"Collins","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.clinthera.2009.05.022_bib34","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0304-3959(86)90228-9","article-title":"The measurement of clinical pain intensity: A comparison of six methods","volume":"27","author":"Jensen","year":"1986","journal-title":"Pain"},{"key":"10.1016\/j.clinthera.2009.05.022_bib35","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/ard.37.4.378","article-title":"Studies with pain rating scales","volume":"37","author":"Downie","year":"1978","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.clinthera.2009.05.022_bib36","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0304-3959(81)90199-8","article-title":"Measurement of pain: Patient preference does not confound pain measurement","volume":"10","author":"Kremer","year":"1981","journal-title":"Pain"},{"key":"10.1016\/j.clinthera.2009.05.022_bib37","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0304-3959(00)00339-0","article-title":"Defining the clinically important difference in pain outcome measures","volume":"88","author":"Farrar","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.clinthera.2009.05.022_bib39","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/jnci\/90.8.611","article-title":"Oral transmucosal fentanyl citrate: Randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients","volume":"90","author":"Farrar","year":"1998","journal-title":"J Natl Cancer Inst."},{"key":"10.1016\/j.clinthera.2009.05.022_bib40","series-title":"Applied Mixed Models in Medicine","author":"Brown","year":"2006"},{"key":"10.1016\/j.clinthera.2009.05.022_bib41","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1054\/bjoc.2001.1680","article-title":"Morphine and alternative opioids in cancer pain: The EAPC recommendations","volume":"84","author":"Hanks","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clinthera.2009.05.022_bib42","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jpainsymman.2006.01.013","article-title":"Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine","volume":"32","author":"Mercadante","year":"2006","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.clinthera.2009.05.022_bib45","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1345\/aph.1L168","article-title":"Pharmacokinetics and pharmacodynamics of intranasal versus intravenous fentanyl in patients with pain after oral surgery","volume":"42","author":"Foster","year":"2008","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinthera.2009.05.022_bib46","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1191\/0269216303pm755oa","article-title":"The acceptability of different routes of administration of analgesia for breakthrough pain","volume":"17","author":"Walker","year":"2003","journal-title":"Palliat Med."}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809001684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809001684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T19:24:15Z","timestamp":1545074655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291809001684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0149291809001684"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2009.05.022","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}